Search Results

Minomic Signs Agreement with US Pathology Laboratory

Minomic International Ltd is pleased to announce the company has executed an agreement with Cirrus Dx, a CLIA Certified “High Complexity” Laboratory, enabling US clinicians and patients early access to the company’s novel test for Prostate Cancer.

February 14, 2019

·

2 min read

Business

Minomic Secures Key Patent in the United States and China

Minomic has received a Notice of Allowance for the company’s patent covering its cell surface antigen for the diagnosis of prostate cancer

September 4, 2018

·

3 min read

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer

Australian immuno-oncology company Minomic International Ltd is pleased to announce the completion of its prospective clinical trial of the company’s novel prostate cancer diagnostic test, MiCheck®.

May 17, 2018

·

2 min read

Deals

Minomic Announces Completion of Demerger of GlyTherix Ltd

Demerger clears the path for therapeutic company capital raising

September 24, 2018

·

2 min read

Drug Development

Minomic Announces Completion of Accrual for Clinical Study of Miltuximab® in Prostate, Bladder and Pancreatic Cancers

No Drug-Related Adverse Effects Found in Patients

July 25, 2018

·

2 min read

Drug Development

Minomic Clinical Study Progresses For Miltuximabtm In Prostate, Bladder, And Pancreatic Cancer

June 29, 2017

·

3 min read

Minomic Announces Completion Of Oversubscribed Capital Raising At AGM

December 1, 2016

·

2 min read

Minomic Launches U.S. Prospective Study Of Micheck Prostate Cancer Test

July 17, 2017

·

3 min read

Minomic Announces Clinical Study Update For MILGa In Prostate, Bladder And Pancreatic Cancers

January 6, 2017

·

3 min read

Business

Minomic: Agreement To Begin First-In-Human Trial Of Novel Prostate Cancer Imaging Agent

October 22, 2015

·

3 min read